SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-18-001468
Filing Date
2018-02-13
Accepted
2018-02-13 18:05:29
Documents
1
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 section16.html 5  
1 FORM 5 section16.xml 5 5176
  Complete submission text file 0001654954-18-001468.txt   6649
Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014 (408) 973-7884
Cellular Biomedicine Group, Inc. (Issuer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 369 LUMO ROAD, HONGSHAN DISTRICT WUHAN F4 430074
Business Address
Meng Xia (Reporting) CIK: 0001710188 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36498 | Film No.: 18605547